Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection

Objectives: To evaluate the frequency and distribution of pelvic nodes metastases, in intermediate-high risk prostate cancer (PCa) patients (pts), who underwent open radical prostatectomy (ORP) and superextended pelvic lymph node dissection (sePLND).Patients and Methods: We retrospectively evaluated...

Full description

Bibliographic Details
Main Authors: Marco Roscigno, Maria Nicolai, Giovanni La Croce, Federico Pellucchi, Manuela Scarcello, Antonino Saccà, Diego Angiolilli, Daniela Chinaglia, Luigi F. Da Pozzo
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fsurg.2018.00052/full
id doaj-b4920419a1ec40819c73ceabed7ada6d
record_format Article
spelling doaj-b4920419a1ec40819c73ceabed7ada6d2020-11-25T00:11:04ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2018-09-01510.3389/fsurg.2018.00052405464Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node DissectionMarco Roscigno0Maria Nicolai1Giovanni La Croce2Federico Pellucchi3Manuela Scarcello4Antonino Saccà5Diego Angiolilli6Daniela Chinaglia7Luigi F. Da Pozzo8Department of Urology, ASST Papa Giovanni XXIII, Bergamo, ItalyDepartment of Urology, ASST Papa Giovanni XXIII, Bergamo, ItalyDepartment of Urology, ASST Papa Giovanni XXIII, Bergamo, ItalyDepartment of Urology, ASST Papa Giovanni XXIII, Bergamo, ItalyFROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, ItalyDepartment of Urology, ASST Papa Giovanni XXIII, Bergamo, ItalyDepartment of Urology, ASST Papa Giovanni XXIII, Bergamo, ItalyDepartment of Pathology, ASST Papa Giovanni XXIII, Bergamo, ItalyDepartment of Urology, ASST Papa Giovanni XXIII, Bergamo, ItalyObjectives: To evaluate the frequency and distribution of pelvic nodes metastases, in intermediate-high risk prostate cancer (PCa) patients (pts), who underwent open radical prostatectomy (ORP) and superextended pelvic lymph node dissection (sePLND).Patients and Methods: We retrospectively evaluated 630 consecutive pts with clinically localized, intermediate-high risk PCa, treated with ORP and sePLND from 2009 to 2016 at a single institution. The sePLND always removed all nodal/fibro-fatty tissue of the internal iliac, external iliac, obturator, common iliac, and presacral regions.Results: Positive lymph nodes (LN+) were found in 133 pts (21.1%). The median number of removed nodes and LN+ was 25 and 1, respectively. LN+ were found in 64 (48.1%), 58 (43.6%), 53 (39.8%), 16 (12%), and 20 (15%) pts and were present as a single site in 27 (20.3%), 22 (16.5%), 20 (15%), 0, and 6 (4.5%) cases in the internal iliac, external iliac, obturator, common iliac, and presacral chain, respectively. An ePLND would have correctly staged 127 (95%) pts but removed all LN+ in only 97 (73%) pts. Presacral nodes harbored LN+ in 20 patients. Among them, 18 were high-risk patients. Moreover, all but 1 pts with common iliac LN+ were in high risk group.Conclusions: These results suggest that removal of presacral and common iliac nodes could be omitted in intermediate risk pts. However, a PLND limited to external iliac, obturator, and internal iliac region may be adequate for nodal staging purpose, but not enough accurate if we aim to remove all possible site of LN+ in high risk pts.https://www.frontiersin.org/article/10.3389/fsurg.2018.00052/fullprostate cancerlymph node dissectionlymph node templatestagingnodal metastases
collection DOAJ
language English
format Article
sources DOAJ
author Marco Roscigno
Maria Nicolai
Giovanni La Croce
Federico Pellucchi
Manuela Scarcello
Antonino Saccà
Diego Angiolilli
Daniela Chinaglia
Luigi F. Da Pozzo
spellingShingle Marco Roscigno
Maria Nicolai
Giovanni La Croce
Federico Pellucchi
Manuela Scarcello
Antonino Saccà
Diego Angiolilli
Daniela Chinaglia
Luigi F. Da Pozzo
Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection
Frontiers in Surgery
prostate cancer
lymph node dissection
lymph node template
staging
nodal metastases
author_facet Marco Roscigno
Maria Nicolai
Giovanni La Croce
Federico Pellucchi
Manuela Scarcello
Antonino Saccà
Diego Angiolilli
Daniela Chinaglia
Luigi F. Da Pozzo
author_sort Marco Roscigno
title Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection
title_short Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection
title_full Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection
title_fullStr Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection
title_full_unstemmed Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection
title_sort difference in frequency and distribution of nodal metastases between intermediate and high risk prostate cancer patients: results of a superextended pelvic lymph node dissection
publisher Frontiers Media S.A.
series Frontiers in Surgery
issn 2296-875X
publishDate 2018-09-01
description Objectives: To evaluate the frequency and distribution of pelvic nodes metastases, in intermediate-high risk prostate cancer (PCa) patients (pts), who underwent open radical prostatectomy (ORP) and superextended pelvic lymph node dissection (sePLND).Patients and Methods: We retrospectively evaluated 630 consecutive pts with clinically localized, intermediate-high risk PCa, treated with ORP and sePLND from 2009 to 2016 at a single institution. The sePLND always removed all nodal/fibro-fatty tissue of the internal iliac, external iliac, obturator, common iliac, and presacral regions.Results: Positive lymph nodes (LN+) were found in 133 pts (21.1%). The median number of removed nodes and LN+ was 25 and 1, respectively. LN+ were found in 64 (48.1%), 58 (43.6%), 53 (39.8%), 16 (12%), and 20 (15%) pts and were present as a single site in 27 (20.3%), 22 (16.5%), 20 (15%), 0, and 6 (4.5%) cases in the internal iliac, external iliac, obturator, common iliac, and presacral chain, respectively. An ePLND would have correctly staged 127 (95%) pts but removed all LN+ in only 97 (73%) pts. Presacral nodes harbored LN+ in 20 patients. Among them, 18 were high-risk patients. Moreover, all but 1 pts with common iliac LN+ were in high risk group.Conclusions: These results suggest that removal of presacral and common iliac nodes could be omitted in intermediate risk pts. However, a PLND limited to external iliac, obturator, and internal iliac region may be adequate for nodal staging purpose, but not enough accurate if we aim to remove all possible site of LN+ in high risk pts.
topic prostate cancer
lymph node dissection
lymph node template
staging
nodal metastases
url https://www.frontiersin.org/article/10.3389/fsurg.2018.00052/full
work_keys_str_mv AT marcoroscigno differenceinfrequencyanddistributionofnodalmetastasesbetweenintermediateandhighriskprostatecancerpatientsresultsofasuperextendedpelviclymphnodedissection
AT marianicolai differenceinfrequencyanddistributionofnodalmetastasesbetweenintermediateandhighriskprostatecancerpatientsresultsofasuperextendedpelviclymphnodedissection
AT giovannilacroce differenceinfrequencyanddistributionofnodalmetastasesbetweenintermediateandhighriskprostatecancerpatientsresultsofasuperextendedpelviclymphnodedissection
AT federicopellucchi differenceinfrequencyanddistributionofnodalmetastasesbetweenintermediateandhighriskprostatecancerpatientsresultsofasuperextendedpelviclymphnodedissection
AT manuelascarcello differenceinfrequencyanddistributionofnodalmetastasesbetweenintermediateandhighriskprostatecancerpatientsresultsofasuperextendedpelviclymphnodedissection
AT antoninosacca differenceinfrequencyanddistributionofnodalmetastasesbetweenintermediateandhighriskprostatecancerpatientsresultsofasuperextendedpelviclymphnodedissection
AT diegoangiolilli differenceinfrequencyanddistributionofnodalmetastasesbetweenintermediateandhighriskprostatecancerpatientsresultsofasuperextendedpelviclymphnodedissection
AT danielachinaglia differenceinfrequencyanddistributionofnodalmetastasesbetweenintermediateandhighriskprostatecancerpatientsresultsofasuperextendedpelviclymphnodedissection
AT luigifdapozzo differenceinfrequencyanddistributionofnodalmetastasesbetweenintermediateandhighriskprostatecancerpatientsresultsofasuperextendedpelviclymphnodedissection
_version_ 1725405400749047808